Skip to main content
FinSpry Logo
FinSpry
AMGN logo
AMGN
(NASDAQ)
Amgen Inc.
$371.50-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Amgen Inc. (AMGN) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Amgen Inc. stock.

Analyst Consensus Rating

Investment consensus from 26 professional research analysts

Consensus Rating

Hold
Based on 26 unique analysts
(39 total ratings in last 90 days)
Very High Confidence12.0:1 Buy/Sell

Average Price Target

$369.88
↓ 0.44% Downside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest AMGN Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Tazeen Ahmad
BofA Securities
SellReiterates
$307.00 → $312.00
Evan Seigerman
BMO Capital
BuyMaintains
$400.00
Michael Yee
UBS
BuyReiterates
$400.00 → $420.00
Mohit Bansal
Wells Fargo
HoldMaintains
$390.00
Vamil Divan
Guggenheim
HoldMaintains
$340.00 → $343.00
Terence Flynn
Morgan Stanley
HoldMaintains
$340.00 → $333.00
Gregory Renza
Truist
HoldMaintains
$327.00 → $340.00
Luca Issi
RBC Capital
BuyMaintains
$370.00
Google Drug Manufacturers - General
TipRanks - Google
BuyReiterates
$412.00
PerPlexity Drug Manufacturers - General
TipRanks - PerPlexity
BuyReiterates
$413.00
Anthropic Drug Manufacturers - General
TipRanks - Anthropic
HoldReiterates
$382.00
DeepSeek Drug Manufacturers - General
TipRanks - DeepSeek
HoldReiterates
$406.00
Evan Seigerman
BMO Capital
BuyMaintains
$400.00
David Amsellem
Piper Sandler
BuyReiterates
$427.00
Salim Syed
Mizuho
HoldMaintains
$303.00
Salim Syed
Mizuho
HoldMaintains
$303.00
Luca Issi
RBC Capital
BuyReiterates
$370.00
Salim Syed
Mizuho
HoldMaintains
$295.00 → $303.00
David Amsellem
Piper Sandler
BuyReiterates
$427.00
Courtney Breen
Bernstein
HoldMaintains
-
Terence Flynn
Morgan Stanley
HoldMaintains
$332.00 → $340.00
Courtney Breen
Bernstein
HoldMaintains
-
Salveen Richter
Goldman Sachs
BuyMaintains
$425.00 → $389.00
PerPlexity Drug Manufacturers - General
TipRanks - PerPlexity
BuyReiterates
$370.00 → $365.00
Yaron Werber
TD Cowen
BuyMaintains
$420.00 → $326.31
Ilya Zubkov
Freedom Capital
BuyUpgrades
$375.00
Hans Engel
Erste
HoldDowngrades
-
Emily Field
Barclays
HoldMaintains
$350.00
Evan Seigerman
BMO Capital
BuyMaintains
$400.00
Vamil Divan
Guggenheim
HoldMaintains
$351.00 → $340.00
Gary Nachman
Canaccord Genuity
HoldMaintains
$366.00
Louise Chen
Scotiabank
BuyMaintains
$385.00
Matt Phipps
William Blair
BuyMaintains
-
Gregory Renza
Truist
HoldMaintains
$325.00 → $327.00
Tazeen Ahmad
BofA Securities
SellReiterates
$304.00 → $307.00
Geoff Meacham
Citi
HoldMaintains
$345.00
Umer Raffat
Evercore ISI Group
BuyMaintains
-
Carter Gould
Cantor Fitzgerald
HoldMaintains
$350.00
Luca Issi
RBC Capital
BuyMaintains
$370.00

Frequently Asked Questions

What is the analyst consensus rating for AMGN?

The analyst consensus rating for AMGN is "Hold" based on 26 analyst recommendations.

What is the average price target for AMGN?

The average 12-month price target for AMGN is $369.88, representing a downside of 0.4% from the current price of $371.50.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.